Table 1 Patient characteristics in this study
| Â | Â | eGFR (ml/min/1.73 m2) | Â | ||
|---|---|---|---|---|---|
|  | ALL | < 60 | 60-89 | ≥ 90 |  |
| Â | (n = 221) | (n = 93) | (n = 106) | (n = 22) | p |
Age (years) | 71 ± 10 | 76 ± 8 | 68 ± 10 | 62 ± 11 | < 0.01 |
Male, n (%) | 185(84) | 74(80) | 92(87) | 19(86) | 0.36 |
Body mass index (kg/m2) | 24.7 ± 3.6 | 24.5 ± 3.7 | 25.0 ± 3.4 | 24.0 ± 4.5 | 0.29 |
Hypertension, n (%) | 157(71) | 77(83) | 77(73) | 12(55) | 0.02 |
Dyslipidemia, n (%) | 183(83) | 75(81) | 89(84) | 19(86) | 0.72 |
Diabetes Mellitus, n (%) | 96(43) | 31(33) | 53(50) | 12(54) | 0.03 |
Smoking (Yes) | 28(13) | 5(5) | 18(16) | 5(23) | 0.02 |
LDL-Cholesterol (mg/dl) | 102 ± 28 | 100 ± 28 | 103 ± 29 | 10.4 ± 26 | 0.77 |
HDL-Cholesterol (mg/dl) | 43 ± 12 | 42 ± 11 | 44 ± 12 | 44 ± 11 | 0.59 |
Triglycerides (mg/dl) | 163(79) | 155(107) | 169(61) | 167(68) | < 0.01 |
Uric acid (mg/dl) | 5.8 ± 1.6 | 6.4 ± 1.6 | 5.5 ± 1.4 | 4.9 ± 1.6 | < 0.01 |
Fasting blood glucose (mg/dl) | 100(25) | 96(18) | 102(34) | 104(28) | < 0.01 |
HOMA-R | 1.7(1.5) | 1.7(1.3) | 1.8(1.7) | 1.3(1.1) | < 0.01 |
HemoglobinA1c (%) | 5.6(1.2) | 5.4(0.8) | 5.7(1.2) | 5.9(1.0) | 0.04 |
hs-CRP(mg/l) | 0.97(2.35) | 1.25(3.27) | 0.82(1.79) | 1.59(2.72) | 0.10 |
Serum A-FABP (ng/ml) | 20.3(13.6) | 26.9(19.5) | 19.6(11.1) | 16.1(4.7) | < 0.01 |
Number of diseased vessels | 1.8 ± 0.8 | 1.9 ± 0.8 | 1.7 ± 0.8 | 1.5 ± 0.7 | 0.12 |
Stenosis score | 9.9 ± 4.9 | 9.3 ± 4.5 | 9.5 ± 5.8 | 10.2 ± 5.1 | 0.71 |
Medications | 28(13) | 5(5) | 18(16) | 5(23) | 0.02 |
   ACEI/ARB, n (%) | 119(54) | 39(43) | 66(62) | 14(64) | 0.18 |
   CCBs, n (%) | 120(54) | 48(52) | 57(38) | 15(68) | 0.39 |
   β-blockers, n (%) | 73(33) | 27(29) | 40(38) | 6(27) | 0.36 |
   Statins, n (%) | 126(57) | 49(52) | 63(59) | 14(63) | 0.50 |